This is a revised application for a new R01 from an established investigator. The PI has requested 3 years of support to investigate the genetic basis of hyperhomocysteinemia and its relationship to vascular pathology in several inbred strains of mice. Levels of Hcy in the C57BL/6J strain are twofold higher than the A/J and C3H/HeJ strains; (C57BL/6J x A/J) F1 animals are similar (but not identical) to the A/J parent; by contrast, (C57BL/6J x C3H/HeJ)F1 animals exhibit so-called heterosis in that their levels are apparently higher than either parent.
In Specific Aim I, the underlying genetic basis of these differences will be investigated by determining Hcy levels in recombinant inbred strains for each of the two pairs, C57BL/6J x C3H/HeJ, and by analyzing 320 progeny from an F2 intercross for QTLs. Hcy levels will also be examined in 21 consomic strains (congenic for each of 21 A/J chromes) in the C57BL/6J background.
In Specific Aim I V, the potential relationship of increased Hcy levels to vascular pathology will be investigated by measuring lipid-containing intimal lesions in large and medium sized arteries from the RI strains and from PL/J (see below). In humans, decreased activity of methylene tetrahydrofolate reductase (MTHFR) contributes to elevated Hcy levels because its product is a cofactor for conversion of Hcy to Methionine. The PI has discovered that the PL/J strain exhibits approximately twofold lower activity of MTHFR than most inbred strains, and, in Specific Aim II, proposes to investigate the genetic basis for this difference bet determining MTHFR activity in 200 progeny from an (C57BL/6J x PL/J)F2 intercross. Finally, in Specific Aim III, the effect of age, sex, pregnancy, and folate supplementation on Hcy levels will be examined in C57BL/6J and A/J MICE, and in C57BL/6J mice that carry one of two mutations, Gli3 or ApoB, that apparently cause a secondary increase in Hcy levels by an unknown mechanism. A part of these experiments, the PI will also complete a survey of Hcy levels in MTHFR activity in additional inbred strains.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL058982-01A1
Application #
2702494
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1998-08-14
Project End
2001-07-31
Budget Start
1998-08-14
Budget End
1999-07-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Genetics
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Kitami, Toshimori; Rubio, Renee; O'Brien, William et al. (2008) Gene-environment interactions reveal a homeostatic role for cholesterol metabolism during dietary folate perturbation in mice. Physiol Genomics 35:182-90
Ernest, Sheila; Carter, Michelle; Shao, Haifeng et al. (2006) Parallel changes in metabolite and expression profiles in crooked-tail mutant and folate-reduced wild-type mice. Hum Mol Genet 15:3387-93
Kitami, Toshimori; Ernest, Sheila; Gallaugher, Laura et al. (2004) Genetic and phenotypic analysis of seizure susceptibility in PL/J mice. Mamm Genome 15:698-703
Shi, Qi; Savage, Jason E; Hufeisen, Sandra J et al. (2003) L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. J Pharmacol Exp Ther 305:131-42
Ernest, Sheila; Christensen, Benedicte; Gilfix, Brian M et al. (2002) Genetic and molecular control of folate-homocysteine metabolism in mutant mice. Mamm Genome 13:259-67
Hoit, B D; Nadeau, J H (2001) Phenotype-driven genetic approaches in mice: high-throughput phenotyping for discovering new models of cardiovascular disease. Trends Cardiovasc Med 11:82-9
Matin, A; Nadeau, J H (2001) Sensitized polygenic trait analysis. Trends Genet 17:727-31
Chadwick, L H; McCandless, S E; Silverman, G L et al. (2000) Betaine-homocysteine methyltransferase-2: cDNA cloning, gene sequence, physical mapping, and expression of the human and mouse genes. Genomics 70:66-73
Faiella, A; Wernig, M; Consalez, G G et al. (2000) A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 9:227-36
Nadeau, J H; Frankel, W N (2000) The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs. Nat Genet 25:381-4

Showing the most recent 10 out of 11 publications